{
    "name": "fibrinogen/thrombin",
    "comment": "Rx",
    "other_names": [
        "Raplixa"
    ],
    "classes": [
        "Hemostatics"
    ],
    "source": "https://reference.medscape.com/drug/raplixa-fibrinogen-thrombin-999982",
    "pregnancy": {
        "common": [
            "Animal reproduction studies have not been conducted",
            "It is also not known whether fibrinogen/thrombin can cause fetal harm when administered to pregnant women or can affect reproductive capacity",
            "Should be given to a pregnant woman only if clearly needed"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk; because many drugs are excreted in human milk, caution should be exercised when administering to breastfeeding women"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Intravascular application",
                "Severe or brisk arterial bleeding",
                "Known anaphylactic or severe systemic reactions to human blood products"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Life-threatening thromboembolic events may result from intravascular application (see Contraindications)",
                "Air or gas embolism has occurred with the use of spray devices using pressure regulators to administer fibrin sealants; this appears to be related to the use of the spray device at higher than manufacturer recommended pressures and in close proximity to the tissue surface; minimize this risk by precisely following manufacturerâ€™s instructions for RaplixaSpray device (see Administration and product prescribing information)",
                "Made from human plasma; risk of transmitting infectious agents (eg, CJD); manufacturing steps designed to reduce this risk are used, as is screening of plasma donors",
                "Hypersensitivity reactions may occur, including hives, generalized urticaria, tightness of chest, wheezing, hypotension, and anaphylaxis; if these symptoms occur, discontinue immediately"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Adverse effects reported were similar to use of gelatin sponge alone",
            "percent": "52"
        },
        {
            "name": "Procedural pain",
            "percent": "26"
        },
        {
            "name": "Nausea",
            "percent": "16"
        },
        {
            "name": "Constipation",
            "percent": "12"
        },
        {
            "name": "Incision site pain",
            "percent": "8"
        },
        {
            "name": "Pyrexia",
            "percent": "7"
        },
        {
            "name": "Anemia",
            "percent": "7"
        },
        {
            "name": "Vomiting",
            "percent": "7"
        },
        {
            "name": "Hypotension",
            "percent": "6"
        },
        {
            "name": "Pruritus",
            "percent": "5"
        },
        {
            "name": "Hypertension",
            "percent": "2"
        },
        {
            "name": "Antithrombin antibodies",
            "percent": null
        }
    ]
}